MLND insider filings

Millendo Therapeutics, Inc. — 3 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-03-19. Screen MLND transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MLND between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Millendo Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2021-03-194Owens Julia C. — Executive Chair, DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2021-03-024Minai-Azary Jennifer Lynn — Chief Financial OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2021-03-024Arcudi III Louis J — President and CEO, DirectorGrant/award (A): 400,000 (derivative) @ $0EDGAR

Recent 8-K events — Millendo Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-11-168-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2026-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-128-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-108-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-11-068-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-10-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-10-208-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2026-10-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-288-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR

Registration filings — Millendo Therapeutics, Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MLND returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs